Nangavarum S Ramamurthy

This inventor holds 9 USPTO granted patents. Top assignees: The State University of New York, Kuraray Co., Ltd.. Active years: 1991-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nangavarum S Ramamurthy. Retrieved from https://idiyas.com/inventor/nangavarum-s-ramamurthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 305(Granted Patents)

Company Filing History:

8 out of 2,046

The State University of New York

Years Active: 1991-2000

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6043231 - Inhibition of excessive phospholipase A.sub.2 activity and/or production (2000-03-28),

2. 5770588 - Non-antibacterial tetracycline compositions of the prevention and (1998-06-23),

3. 5523297 - Inhibition of excessive phospholipase A.sub.2 activity and/or production (1996-06-04),

4. 5459135 - Composition comprising indomethacin [non-steroidal anti-inflammatory (1995-10-17),

5. 5321017 - Composition comprising fluriprofen and effectively non-antibacterial (1994-06-14),

6. 5308839 - Composition comprising non-steroidal anti-inflammatory agent tenidap and (1994-05-03),

7. 5258371 - Method to reduce connective tissue destruction (1993-11-02),

8. 5223248 - Non-antibacterial tetracycline compositions possessing antiplaque (1993-06-29),

9. 5045538 - Inhibition of wasting and protein degradation of mammalian muscle by (1991-09-03),

Title: The Innovations of Nangavarum S Ramamurthy in Pharmaceutical Science

Introduction

Nangavarum S Ramamurthy is a prominent inventor based in Smithtown, NY, recognized for his significant contributions to the field of pharmaceutical sciences. With a total of nine patents to his name, Ramamurthy has made remarkable strides in the development of methods and compositions aimed at enhancing dental and therapeutic health.

Latest Patents

Among his latest patents, Ramamurthy has developed a method for treating mammals suffering from conditions associated with excess phospholipase A.sub.2 activity. This innovative approach involves administering an effective amount of a non-antimicrobial tetracycline, which is crucial for inhibiting the excessive activity of this enzyme. Additionally, he has introduced methods designed to prevent root caries formation on mammalian tooth surfaces. These methods utilize a non-antibacterial tetracycline, which is not systemically absorbed into the bloodstream, and can be incorporated into various oral hygiene products like dentifrices, lozenges, and chewing gums.

Career Highlights

Throughout his career, Ramamurthy has been associated with renowned institutions such as the Research Foundation of State University of New York and Kuraray Co., Ltd. His work at these organizations has laid the foundation for his significant inventions and advancements in dental health care.

Collaborations

Ramamurthy has collaborated with notable industry professionals, including Lorne M Golub and Thomas F McNamara. These partnerships have been instrumental in driving research forward and enhancing the scope of his patented innovations.

Conclusion

Nangavarum S Ramamurthy continues to be an influential figure in the realm of pharmaceutical innovations. His groundbreaking patents not only advance scientific understanding but also provide practical solutions for dental health, demonstrating the impactful role of inventors in improving health outcomes for mammals.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]